Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Finasteride/latanoprost/minoxidil - Triple Hair

Next Previous
X
Search
Drug Profile

Finasteride/latanoprost/minoxidil - Triple Hair

Alternative Names: Finasteride/minoxidil/latanoprost - Triple Hair; Latanoprost/minoxidil/finasteride/- Triple Hair; Minoxidil/finasteride/latanoprost - Triple Hair; TH-07; Therapy-07

Latest Information Update: 19 Dec 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Triple Hair
  • Class Androstenes; Antiacnes; Antiandrogens; Antiglaucomas; Antihypertensives; Antineoplastics; Azasteroids; Peripheral vasodilators; Piperidines; Prostaglandins; Skin disorder therapies; Small molecules
  • Mechanism of Action Cholestenone 5 alpha-reductase inhibitors; Potassium channel agonists; Prostaglandin F2 alpha agonists; Testosterone antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Alopecia

Most Recent Events

  • 17 Oct 2023 Therapy 07 licensed to Mother’s Pharmaceutical in South Kora
  • 03 Feb 2023 Finasteride/latanoprost/minoxidil - Triple Hair is available for licensing as of 03 Feb 2023. https://triplehair.ca/contact/ (Triple Hair pipeline, December 2022)
  • 21 Dec 2022 Phase-II clinical trials in Alopecia in Canada (Topical)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top